FORFARMERS NV (FFARM.AS) Stock Fundamental Analysis
Europe - AMS:FFARM - NL0011832811 - Common Stock
4.29 EUR
-0.01 (-0.23%)
Overall FFARM gets a fundamental rating of 6 out of 10. We evaluated FFARM against 59 industry peers in the Food Products industry. FFARM has an average financial health and profitability rating. A decent growth rate in combination with a cheap valuation! Better keep an eye on FFARM. These ratings could make FFARM a good candidate for value investing.
1. Profitability
1.1 Basic Checks
In the past year FFARM was profitable.
In the past year FFARM had a positive cash flow from operations.
FFARM had positive earnings in 4 of the past 5 years.
Each year in the past 5 years FFARM had a positive operating cash flow.
1.2 Ratios
FFARM has a better Return On Assets (4.86%) than 66.10% of its industry peers.
With a decent Return On Equity value of 15.59%, FFARM is doing good in the industry, outperforming 79.66% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 9.72%, FFARM belongs to the top of the industry, outperforming 81.36% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for FFARM is below the industry average of 7.03%.
The last Return On Invested Capital (9.72%) for FFARM is above the 3 year average (4.52%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.86% | ||
| ROE | 15.59% | ||
| ROIC | 9.72% |
ROA(3y)1.66%
ROA(5y)1.6%
ROE(3y)4.87%
ROE(5y)4.38%
ROIC(3y)4.52%
ROIC(5y)5.03%
1.3 Margins
With a Profit Margin value of 1.72%, FFARM is not doing good in the industry: 62.71% of the companies in the same industry are doing better.
In the last couple of years the Profit Margin of FFARM has grown nicely.
FFARM's Operating Margin of 2.47% is on the low side compared to the rest of the industry. FFARM is outperformed by 67.80% of its industry peers.
FFARM's Operating Margin has been stable in the last couple of years.
FFARM has a Gross Margin of 18.91%. This is amonst the worse of the industry: FFARM underperforms 81.36% of its industry peers.
FFARM's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.47% | ||
| PM (TTM) | 1.72% | ||
| GM | 18.91% |
OM growth 3Y22.91%
OM growth 5Y-1.24%
PM growth 3Y36.41%
PM growth 5Y9.73%
GM growth 3Y4.94%
GM growth 5Y1.08%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), FFARM is creating some value.
FFARM has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for FFARM has been reduced compared to 5 years ago.
FFARM has a worse debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 3.68 indicates that FFARM is not in any danger for bankruptcy at the moment.
FFARM has a Altman-Z score of 3.68. This is amongst the best in the industry. FFARM outperforms 88.14% of its industry peers.
FFARM has a debt to FCF ratio of 2.61. This is a good value and a sign of high solvency as FFARM would need 2.61 years to pay back of all of its debts.
The Debt to FCF ratio of FFARM (2.61) is better than 86.44% of its industry peers.
FFARM has a Debt/Equity ratio of 0.33. This is a healthy value indicating a solid balance between debt and equity.
FFARM has a Debt to Equity ratio of 0.33. This is in the better half of the industry: FFARM outperforms 79.66% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.33 | ||
| Debt/FCF | 2.61 | ||
| Altman-Z | 3.68 |
ROIC/WACC1.49
WACC6.52%
2.3 Liquidity
FFARM has a Current Ratio of 1.10. This is a normal value and indicates that FFARM is financially healthy and should not expect problems in meeting its short term obligations.
FFARM has a worse Current ratio (1.10) than 62.71% of its industry peers.
A Quick Ratio of 0.81 indicates that FFARM may have some problems paying its short term obligations.
FFARM has a Quick ratio of 0.81. This is comparable to the rest of the industry: FFARM outperforms 47.46% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.1 | ||
| Quick Ratio | 0.81 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 171.25% over the past year.
The Earnings Per Share has been growing by 14.71% on average over the past years. This is quite good.
The Revenue has grown by 8.76% in the past year. This is quite good.
Measured over the past years, FFARM shows a small growth in Revenue. The Revenue has been growing by 2.20% on average per year.
EPS 1Y (TTM)171.25%
EPS 3Y40.88%
EPS 5Y14.71%
EPS Q2Q%440%
Revenue 1Y (TTM)8.76%
Revenue growth 3Y0.93%
Revenue growth 5Y2.2%
Sales Q2Q%15.97%
3.2 Future
The Earnings Per Share is expected to grow by 29.63% on average over the next years. This is a very strong growth
FFARM is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.25% yearly.
EPS Next Y105.48%
EPS Next 2Y47.58%
EPS Next 3Y29.63%
EPS Next 5YN/A
Revenue Next Year12.58%
Revenue Next 2Y7.12%
Revenue Next 3Y5.25%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 7.80, which indicates a rather cheap valuation of FFARM.
Based on the Price/Earnings ratio, FFARM is valued cheaply inside the industry as 88.14% of the companies are valued more expensively.
FFARM is valuated cheaply when we compare the Price/Earnings ratio to 27.30, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 7.86, the valuation of FFARM can be described as very cheap.
86.44% of the companies in the same industry are more expensive than FFARM, based on the Price/Forward Earnings ratio.
FFARM is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.73, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.8 | ||
| Fwd PE | 7.86 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of FFARM indicates a rather cheap valuation: FFARM is cheaper than 93.22% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of FFARM indicates a rather cheap valuation: FFARM is cheaper than 86.44% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 5.82 | ||
| EV/EBITDA | 3.68 |
4.3 Compensation for Growth
FFARM's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
FFARM's earnings are expected to grow with 29.63% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.07
PEG (5Y)0.53
EPS Next 2Y47.58%
EPS Next 3Y29.63%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 4.42%, FFARM is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 3.25, FFARM pays a better dividend. On top of this FFARM pays more dividend than 83.05% of the companies listed in the same industry.
FFARM's Dividend Yield is rather good when compared to the S&P500 average which is at 2.45.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.42% |
5.2 History
The dividend of FFARM decreases each year by -12.97%.
Dividend Growth(5Y)-12.97%
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
FFARM pays out 41.76% of its income as dividend. This is a bit on the high side, but may be sustainable.
DP41.76%
EPS Next 2Y47.58%
EPS Next 3Y29.63%
AMS:FFARM (9/12/2025, 7:00:00 PM)
4.29
-0.01 (-0.23%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)
Earnings (Next)
Inst Owners3.07%
Inst Owner ChangeN/A
Ins Owners5.48%
Ins Owner ChangeN/A
Market Cap383.01M
Analysts86
Price Target4.81 (12.12%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.42% |
Yearly Dividend0.15
Dividend Growth(5Y)-12.97%
DP41.76%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)9.27%
PT rev (3m)9.27%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)20.48%
EPS NY rev (3m)20.48%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)5.22%
Revenue NY rev (3m)5.22%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.8 | ||
| Fwd PE | 7.86 | ||
| P/S | 0.13 | ||
| P/FCF | 5.82 | ||
| P/OCF | 3.53 | ||
| P/B | 1.17 | ||
| P/tB | 1.8 | ||
| EV/EBITDA | 3.68 |
EPS(TTM)0.55
EY12.82%
EPS(NY)0.55
Fwd EY12.72%
FCF(TTM)0.74
FCFY17.18%
OCF(TTM)1.22
OCFY28.33%
SpS33.18
BVpS3.66
TBVpS2.39
PEG (NY)0.07
PEG (5Y)0.53
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.86% | ||
| ROE | 15.59% | ||
| ROCE | 12.33% | ||
| ROIC | 9.72% | ||
| ROICexc | 10.81% | ||
| ROICexgc | 13.66% | ||
| OM | 2.47% | ||
| PM (TTM) | 1.72% | ||
| GM | 18.91% | ||
| FCFM | 2.22% |
ROA(3y)1.66%
ROA(5y)1.6%
ROE(3y)4.87%
ROE(5y)4.38%
ROIC(3y)4.52%
ROIC(5y)5.03%
ROICexc(3y)5.02%
ROICexc(5y)6.01%
ROICexgc(3y)6.45%
ROICexgc(5y)7.81%
ROCE(3y)5.89%
ROCE(5y)6.6%
ROICexcg growth 3Y23.14%
ROICexcg growth 5Y0.01%
ROICexc growth 3Y22.42%
ROICexc growth 5Y1.04%
OM growth 3Y22.91%
OM growth 5Y-1.24%
PM growth 3Y36.41%
PM growth 5Y9.73%
GM growth 3Y4.94%
GM growth 5Y1.08%
F-Score7
Asset Turnover2.82
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.33 | ||
| Debt/FCF | 2.61 | ||
| Debt/EBITDA | 0.84 | ||
| Cap/Depr | 74.39% | ||
| Cap/Sales | 1.44% | ||
| Interest Coverage | 11.42 | ||
| Cash Conversion | 83.14% | ||
| Profit Quality | 129.02% | ||
| Current Ratio | 1.1 | ||
| Quick Ratio | 0.81 | ||
| Altman-Z | 3.68 |
F-Score7
WACC6.52%
ROIC/WACC1.49
Cap/Depr(3y)70.12%
Cap/Depr(5y)76.46%
Cap/Sales(3y)1.08%
Cap/Sales(5y)1.25%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)171.25%
EPS 3Y40.88%
EPS 5Y14.71%
EPS Q2Q%440%
EPS Next Y105.48%
EPS Next 2Y47.58%
EPS Next 3Y29.63%
EPS Next 5YN/A
Revenue 1Y (TTM)8.76%
Revenue growth 3Y0.93%
Revenue growth 5Y2.2%
Sales Q2Q%15.97%
Revenue Next Year12.58%
Revenue Next 2Y7.12%
Revenue Next 3Y5.25%
Revenue Next 5YN/A
EBIT growth 1Y85.53%
EBIT growth 3Y24.06%
EBIT growth 5Y0.93%
EBIT Next Year188.1%
EBIT Next 3Y50.85%
EBIT Next 5YN/A
FCF growth 1Y54%
FCF growth 3Y40.78%
FCF growth 5Y-6.65%
OCF growth 1Y39.25%
OCF growth 3Y8.69%
OCF growth 5Y-6.1%